| Literature DB >> 18823911 |
Marieke M van der Zalm1, Bart E van Ewijk, Berry Wilbrink, Cuno S P M Uiterwaal, Tom F W Wolfs, Cornelis K van der Ent.
Abstract
OBJECTIVES: To investigate the occurrence of respiratory pathogens in samples from children with and without respiratory symptoms and to identify whether age and/ or coinfections modify the impact of respiratory pathogens on symptoms. STUDYEntities:
Mesh:
Year: 2008 PMID: 18823911 PMCID: PMC7094528 DOI: 10.1016/j.jpeds.2008.08.036
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406
Characteristics of the study group (n =18)
| Sex, M/F | 3/15 |
| Age, years | 3.67 (0-7) |
| 0-2 | 8 |
| 3-4 | 6 |
| 5-7 | 4 |
| Number of siblings/child | 1.50 (0-4) |
| Number of symptomatic episodes/child | 9.50 (4-15) |
| Number of asymptomatic infections/child | 3.00 (0-9) |
Data are expressed as median and range in parentheses.
Respiratory pathogens detected in asymptomatic and symptomatic episodes in young children
| Asymptomatic samples (n = 65) | Symptomatic samples (n = 165) | ||
|---|---|---|---|
| Any pathogen | 26 (40) | 93 (56) | .03 |
| Human rhinovirus | 14 (22) | 38 (23) | .88 |
| Enterovirus | 2 (3) | 7 (4) | NA |
| Coronaviruses (total) | 5 (8) | 15 (9) | .38 |
| HCoV OC43 | 1 (2) | 6 (4) | |
| HCoV 229E | 4 (6) | 6 (4) | |
| HCoV NL63 | 0 | 3 (2) | |
| RSV B | 0 | 1 (1) | NA |
| Influenza virus A | 0 | 1 (1) | NA |
| Human metapneumovirus | 0 | 0 | NA |
| Adenovirus | 0 | 1 (1) | NA |
| 3 (5) | 2 (1) | NA | |
| 0 | 0 | NA | |
| Multiple pathogens | 2 (3) | 28 (17) | .02 |
NA, not applicable; HcoV, human coronavirus.
Data are presented as numbers with percentage of the samples in parentheses. P values are calculated with the 2-tailed χ2 test.
Combinations of respiratory pathogens found in samples with multiple pathogens detected
| Asymptomatic episodes (n = 2) | Symptomatic episodes (n = 28) | |
|---|---|---|
| HRV + CP | 1 | 3 |
| HRV + HCoV OC43 | 1 | 3 |
| HRV + MP | 4 | |
| HRV + HCoV 229E | 5 | |
| HRV +IVB | 1 | |
| HRV + RSVB | 1 | |
| HRV + CP + MP | 1 | |
| HRV + CP + RSVB | 1 | |
| HRV + MP + HCoV OC43 | 1 | |
| HCoV 229E + HCoV OC43 | 1 | |
| HCoV 229E + HCoV NL63 | 1 | |
| HCoV 229E + CP | 1 | |
| HCoV 229E + hMPV + EV | 1 | |
| HCoV 229E + HCoV OC43 + hMPV | 1 | |
| HCoV 229E + HCoV OC43 + EV | 1 | |
| HCoV OC43 + RSVA | 1 | |
| HCoV OC43 + RSVB | 1 |
HRV, human rhinovirus; CP, Chlamydophila pneumoniae; HcoV, human coronavirus; MP, Mycoplasma pneumoniae; IVB, influenza virus B; hMPV, human metapneumovirus; EV, enterovirus.
Figure 1A selection of pathogen- positive episodes. The proportion of symptomatic and asymptomatic episodes was studied in 3 different age categories.
Figure 2Percentages of the symptomatic and asymptomatic samples related to the number of pathogens detected.